Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin
Sevim Dalva-Aydemir, Richa Bajpai, Maylyn Martinez, Kehinde U.A. Adekola, Irawati Kandela, Changyong Wei, Seema Singhal, Jennifer E. Koblinski, Noopur S. Raje, Steven T. Rosen, Mala Shanmugam*
Dive into the research topics of 'Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin'. Together they form a unique fingerprint.